Alpha 2.0
Login Register
» Articles » PMID: 24764556

Dangerous Power: Mitochondria in CLL Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2014 Apr 26
PMID 24764556
Citations 5
Authors
Li Jia
John G Gribben
Affiliations
Soon will be listed here.
Citing Articles

Acute Myeloid Leukaemia and Acute Lymphoblastic Leukaemia Classification and Metabolic Characteristics for Informing and Advancing Treatment.

Wemyss C, Jones E, Stentz R, Carding S Cancers (Basel). 2025; 16(24.

PMID: 39766036 PMC: 11675077. DOI: 10.3390/cancers16244136.

Using Human 'Personalized' Cybrids to Identify Drugs/Agents That Can Regulate Chronic Lymphoblastic Leukemia Mitochondrial Dysfunction.

Singh L, Atilano S, Chwa M, Singh M, Ozgul M, Nesburn A Int J Mol Sci. 2023; 24(13).

PMID: 37446202 PMC: 10341973. DOI: 10.3390/ijms241311025.

A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs.

Panina S, Baran N, Brasil da Costa F, Konopleva M, Kirienko N Cell Death Dis. 2019; 10(8):617.

PMID: 31409768 PMC: 6692368. DOI: 10.1038/s41419-019-1851-3.

Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter.

Haskin G, Kogan M Integr Med (Encinitas). 2019; 17(1):51-56.

PMID: 30962776 PMC: 6380985.

Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-Immunotherapy.

Gdynia G, Robak T, Kopitz J, Heller A, Grekova S, Duglova K EBioMedicine. 2018; 32:125-133.

PMID: 29884457 PMC: 6021262. DOI: 10.1016/j.ebiom.2018.05.030.